Table 1.
Patient No | Type/Side | Immunohistochemistry | Image findings | |||||
---|---|---|---|---|---|---|---|---|
ER | PR | HER2/neu | MIB-1 Index | PET Rating | LN No. and location (CT) |
LN size /mm (CT) | ||
1 | NST / bilateral | + | + | - | 40% | pos | left: > 5 ax / 3 IMLN |
3x3 - 11x7 |
2 | NST / left | + | + | - | 40% | pos | > 5 ax / 4 IMLN | 15x10 - 11x6 |
3 | ILC / right | + | + | - | 27% | pos | 1 ax | 10x9 |
4 | NST / right | - | - | - | 90% | neg | 2 IMLN | 5x3 - 24x20 |
5 | NST / right | + | + | - | 8% | pos | 1 ax | 14x6 |
6 | ILC / right | + | + | - | 30% | pos | / | / |
7 | NST / bilateral | right: + left: - |
right: + left: - |
right: - left: + |
right: 18 % left: 20 % |
right: pos left: neg |
/ | / |
8 | NST / left | - | - | - | 80% | neg | 5 IMLN | 7x7 - 11x14 |
9 | NST / bilateral | + | + | - | right: 18 % left: 15 % |
pos | right: 2 ax / 1 IMLN |
3x4 - 11x5 |
10 | ILC / left | + | + | - | 15% | pos | / | / |
11 | NST / right | + | + | - | 16% | pos | / | / |
12 | NST / right | - | - | - | 60% | neg | > 5 ax / 1 IMLN / 1 scl / 1 spc | 6x6 - 9x9 |
13 | MC / right | + | + | + | 20% | neg | > 5 ax | 9x8 - 42x24 |
14 | NST / right | + | + | - | 23% | pos | > 5 ax / 5 IMLN / 2 med / 1 hil | 3x4 - 22x15 |
15 | NST / left | + | + | - | 38% | pos | > 5 ax / 4 IMLN / 9 spc / 1 cl | 3x3 - 14x19 |
Abbreviations: pos, positive; neg, negative; LN, lymph node; ax, axillary; IMLN, internal mammary lymph node; med, mediastinal; hil, hilar; spc, subpectoral; scl, supraclavicular; cl, contralateral axillary; for additional abbreviations see text.